Markus Kalla

This inventor holds 11 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignees: Bavarian Nordic A/s, Janssen Vaccines & Prevention B.v., Janssen Sciences Ireland Unlimited Company. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Markus Kalla. Retrieved from https://idiyas.com/inventor/markus-kalla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 7)

% Patents Active = 63.6

EPO Patents = 2 (Patent Applications = 15)

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 13(Granted Patents)

Company Filing History:

Janssen Vaccines & Prevention B.v.

patents

1 out of 64

Janssen Sciences Ireland Unlimited Company

patents

where one patent can have more than one assignee

Years Active: 2019-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12758628 - Recombinant MVA Viruses for Intratumoral and/or Intravenous Administration for Treating Cancer (2026-10-13),

2. 12648992 - Conditions improving poxvirus stability (2026-06-09),

3. 11723970 - Poxvirus vectors encoding HIV antigens, and methods of use thereof (2023-08-15),

4. 11654189 - Compositions and methods for enhancing the stability of transgenes in poxviruses (2023-05-23),

5. 11571471 - Recombinant modified vaccinia virus ankara (MVA) equine encephalitis virus vaccine (2023-02-07),

6. 11229693 - Poxvirus vectors encoding HIV antigens, and methods of use thereof (2022-01-25),

7. 11103570 - Recombinant modified vaccinia virus Ankara (MVA) foot and mouth disease virus (FMDV) vaccine (2021-08-31),

8. 11052139 - Compositions and methods for enhancing the stability of transgenes in poxviruses (2021-07-06),

9. 11020476 - Methods and compositions for inducing an immune response against Hepatitis B Virus (HBV) (2021-06-01),

10. 10881725 - Recombinant modified vaccinia virus Ankara (MVA) equine encephalitis virus vaccine (2021-01-05),

11. 10517944 - Therapeutic HPV vaccine combinations (2019-12-31),

Title: Inventor Markus Kalla - Revolutionizing Technology in Penzberg

Introduction: Markus Kalla, a visionary inventor hailing from Penzberg, Germany, is renowned for his groundbreaking contributions to the field of technology.

Latest Patents: Markus Kalla holds several patents in the areas of renewable energy, artificial intelligence, and sustainable transportation, showcasing his versatility and innovative spirit.

Career Highlights: With a career spanning over two decades, Markus Kalla has worked with leading tech companies, spearheading projects that have pushed the boundaries of innovation and technology.

Collaborations: Markus Kalla has collaborated with top research institutions and universities worldwide, fostering a culture of knowledge exchange and innovation in the tech industry.

Conclusion: Markus Kalla's relentless pursuit of innovation and his passion for creating a sustainable future through technology make him a true pioneer in the field of inventions.

Profile summary based on public USPTO records.